AI summary
Heineken warns UK pubs that the surge in weight-loss drugs like Wegovy may reduce alcohol cravings, threatening beer and cider sales.
AI-generated summary. Check the original reporting for context and accuracy.
Boom in weight-loss drugs could lead to fall in beer sales, Heineken warns UK pubs
Source excerpt
This is the available feed excerpt, which may be shortened or in the publisher’s original language.
World’s second largest brewer says use of drugs such as Wegovy can reduce desire to drink alcoholHeineken has warned British bars and pubs that the boom in popularity of weight-loss drugs could lead to a fall in sales of beer and cider.The world’s second-largest brewer sent a presentation to British hospitality customers earlier this month that said the use of GLP-1 medication – such as Ozempic and Wegovy – could reduce the desire to drink alcohol. This in turn could result in “fullness and fewer serves” of pints in pubs and bars, it added. Continue reading...
About priority
An automated sorting aid based on source trust, keywords, and entities, on a scale of 1–12. High: 9–12; medium: 6–8; low: 1–5. It does not measure urgency, verify reporting, or indicate editorial endorsement.